Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZUBSOLV ® safely and effectively. See full prescribing information for ZUBSOLV. ZUBSOLV (buprenorphine and naloxone sublingual tablets), CIII Initial U.S. Approval: 2002
Medication labelWhy this: Advisory · dailymed-prescription
ZUBSOLV is indicated for treatment of opioid dependence. ZUBSOLV should be used as part of a complete treatment plan that includes counseling and psychosocial support.
- generic_name
- buprenorphine hydrochloride and naloxone hydrochloride
- product_names
- buprenorphine hydrochloride and naloxone hydrochloride
- ndc
- 54123-907, 54123-907-30, 54123-914, 54123-914-30, 54123-929, 54123-929-30, 54123-957, 54123-957-30, 54123-986, 54123-986-30, 54123-114, 54123-114-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en